Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000519824 | SCV000621549 | uncertain significance | not provided | 2021-03-26 | criteria provided, single submitter | clinical testing | Not observed at a significant frequency in large population cohorts (Lek et al., 2016); In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 25741868) |
Fulgent Genetics, |
RCV000764679 | SCV000895809 | uncertain significance | COG5-congenital disorder of glycosylation | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000764679 | SCV002236112 | uncertain significance | COG5-congenital disorder of glycosylation | 2022-10-17 | criteria provided, single submitter | clinical testing | This sequence change replaces leucine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 391 of the COG5 protein (p.Leu391Val). This variant is present in population databases (rs762031095, gnomAD 0.003%). This variant has not been reported in the literature in individuals affected with COG5-related conditions. ClinVar contains an entry for this variant (Variation ID: 452719). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C15"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |